Founder uses Claude to read rare lymphoma scans, skips radiation

Conno Christou, 35, co-founder of Keragon, was diagnosed in 2025 with a rare non-Hodgkin's lymphoma and during chemotherapy fed lab results, imaging and wearable data into Anthropic's large language model Claude, using it to help interpret an ambiguous end-of-treatment PET scan as a false positive rather than a relapse and to avoid radiation, TechCrunch reported.